36 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

• Helius Medical Tech, Inc. HSDT stock increased by 88.1% to $0.79 during Thursday's pre-market session. The market cap stands at $15.6 million.
• Paratek Pharmaceuticals, Inc. PRTK shares moved upwards by 41.7% to $4.18. The market cap stands at $102.6 million.
• Catalyst Biosciences, Inc. CBIO shares surged 27.9% to $6.10. The market cap seems to be at $65.5 million.
• Rite Aid, Inc. RAD stock surged 26.9% to $10.60. The market cap stands at $504.8 million.
• Bionano Genomics, Inc. BNGO shares increased by 10.8% to $1.13. The market cap stands at $20.9 million.
• Selecta Biosciences, Inc. SELB shares increased by 8.9% to $1.59. The market value of their outstanding shares is at $70.8 million.
• Bellerophon Therapeutics, Inc. BLPH shares rose 8.7% to $0.36. The market cap seems to be at $31.0 million.
• Inovio Pharmaceuticals, Inc. INO stock increased by 8.0% to $2.84. The market cap stands at $210.9 million. The most recent rating by Roth Capital, on December 19, is at Buy, with a price target of $13.00.
• Axsome Therapeutics, Inc. AXSM stock moved upwards by 8.0% to $96.70. The market cap stands at $1.3 billion. The most recent rating by Cantor Fitzgerald, on December 16, is at Overweight, with a price target of $104.00.
• Sunesis Pharmaceuticals, Inc. SNSS stock increased by 6.5% to $0.31. The market cap stands at $64.8 million.
• ObsEva, Inc. OBSV shares increased by 6.4% to $3.16. The market cap seems to be at $337.6 million. The most recent rating by H.C. Wainwright, on December 19, is at Buy, with a price target of $40.00.
• TherapeuticsMD, Inc. TXMD shares surged 5.4% to $2.44. The market cap seems to be at $721.1 million.
• Karuna Therapeutics, Inc. KRTX stock increased by 4.9% to $69.25. The market cap stands at $1.6 billion. The most recent rating by Stifel Nicolaus, on December 19, is at Buy, with a price target of $126.00.
• Genfit, Inc. GNFT shares increased by 4.9% to $17.61. The market value of their outstanding shares is at $552.9 million.
• Moleculin Biotech, Inc. MBRX stock rose 3.8% to $0.99. The market value of their outstanding shares is at $48.9 million. The most recent rating by Oppenheimer, on October 17, is at Outperform, with a price target of $2.00.
• Seattle Genetics, Inc. SGEN stock rose 3.8% to $117.04. The market cap seems to be at $18.4 billion. The most recent rating by Oppenheimer, on December 12, is at Outperform, with a price target of $124.00.
• Fortress Biotech, Inc. FBIO stock rose 3.7% to $2.25. The market cap stands at $99.1 million. The most recent rating by B. Riley, on December 18, is at Buy, with a price target of $9.00.
• Macrogenics, Inc. MGNX stock increased by 3.5% to $10.95. The market cap seems to be at $463.2 million. The most recent rating by Cantor Fitzgerald, on December 19, is at Overweight, with a price target of $17.00.
• Biocept, Inc. BIOC shares rose 2.9% to $0.24. The market cap seems to be at $16.4 million.
• Xenetic Biosciences, Inc. XBIO shares increased by 2.6% to $1.59. The market cap stands at $6.8 million.
• Adamas Pharmaceuticals, Inc. ADMS stock moved upwards by 2.5% to $3.76. The market value of their outstanding shares is at $114.4 million. The most recent rating by Cantor Fitzgerald, on December 17, is at Neutral, with a price target of $7.00.
• Epizyme, Inc. EPZM stock moved upwards by 2.0% to $20.50. The market cap stands at $1.0 billion. The most recent rating by Morgan Stanley, on December 06, is at Overweight, with a price target of $22.00.
• Outlook Therapeutics, Inc. OTLK shares moved upwards by 1.7% to $1.17. The market cap seems to be at $46.0 million.
• Mirum Pharmaceuticals, Inc. MIRM shares moved upwards by 1.6% to $24.15. The market value of their outstanding shares is at $165.0 million.
• Abeona Therapeutics, Inc. ABEO stock surged 1.5% to $4.00. The market value of their outstanding shares is at $120.9 million.

Losers

• Ekso Bionics Holdings, Inc. EKSO shares decreased by 25.9% to $0.40 during Thursday's pre-market session. The market value of their outstanding shares is at $43.0 million. The most recent rating by H.C. Wainwright, on October 28, is at Buy, with a price target of $1.20.
• Minerva Neurosciences, Inc. NERV stock plummeted 18.3% to $5.63. The market value of their outstanding shares is at $184.9 million. The most recent rating by H.C. Wainwright, on December 19, is at Buy, with a price target of $20.00.
• Zafgen, Inc. ZFGN stock fell 5.3% to $0.68. The market cap seems to be at $27.6 million.
• Amarin Corp, Inc. AMRN shares decreased by 2.5% to $20.30. The market cap stands at $5.8 billion. The most recent rating by Stifel, on December 16, is at Hold, with a price target of $26.00.
• Ocugen, Inc. OCGN shares declined 2.3% to $0.38. The market value of their outstanding shares is at $19.7 million. The most recent rating by Chardan Capital, on November 27, is at Buy, with a price target of $2.00.
• Exicure, Inc. XCUR shares plummeted 2.0% to $2.90. The market value of their outstanding shares is at $256.8 million. The most recent rating by Guggenheim, on November 20, is at Buy, with a price target of $9.00.
• Diffusion Pharmaceuticals, Inc. DFFN stock fell 1.8% to $0.39. The market cap stands at $3.9 million. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.
• Solid Biosciences, Inc. SLDB shares plummeted 1.6% to $3.90. The market cap seems to be at $508.2 million. The most recent rating by Nomura, on December 18, is at Buy, with a price target of $10.00.
• Obalon Therapeutics, Inc. OBLN stock plummeted 1.6% to $1.88. The market cap stands at $12.9 million.
• Sesen Bio, Inc. SESN shares plummeted 1.4% to $0.91. The market value of their outstanding shares is at $123.5 million.
• Sanofi, Inc. SNY shares decreased by 1.1% to $49.79. The market cap stands at $115.4 billion. According to the most recent rating by Barclays, on December 06, the current rating is at Underweight.